PUBLISHED WORKS

August 2016

Bardoxolone methyl prevents obesity and hypothalamic dysfunction

Camer D et al. Chem Biol Interact 2016;256:178-87.

Read publication >

June 2015

Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory

Camer D et al. Prog Neuropsychopharmacol Biol Psychiatry 2015;59:68-75.

Read publication >

September 2014

Comment on: Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing modulation (sic) in rats

Camer D et al. Chem Biol Interact 2014;223:116.

Read publication >

January 2016

Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet

Camer D et al. Chem Biol Interact 2016;243:10-8.

Read publication >

March 2015

Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?

Camer D et al. J Card Fail 2015;21(3):258-9.

Read publication >

April 2014

The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications

Camer D et al. Mol Nut Food Res 2014;58(8):1750-9.

Read publication >

September 2015

Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet

Camer D et al. Mol Cell Endocrinol 2015;412:36-43.

Read publication >

October 2014

The endothelin pathway: a protective or detrimental target of bardoxolone methyl on cardiac function in patients with advanced chronic kidney disease?

Camer D et al. Am J Nephrol 2014;40(3):288-90.

Read publication >

CO-AUTHORED PUBLICATIONS

Feng Y, Yu Y, Wang S, Ren J, Camer D et al. Pharm Biol 2016;54(6):1027-34.
Dinh HL C, Szabo A, Yu Y, Camer D et al. ScientificWorldJournal 2015;2015:549352.
Dinh HL C, Szabo A, Yu Y, Camer D et al. Nutrients 2015;7(6):4705-23.
Cusick A, Camer D et al. Journal of Peer Learning 2015;8:18-33.
Cheng L, Yu Y, Szabo A, Wu Y, Wang H, Camer D et al. J Nut Biochem 2015;26(5):541-8.
Dinh HL C, Szabo A, Camer D et al. Chem Biol Interact 2015;229:1-8.

PUBLISHED WORKS

Bardoxolone methyl prevents obesity and hypothalamic dysfunction

​

​

Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory

​

Comment on: Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing modulation (sic) in rats

​

Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet

Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?

​

​

The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications

​

Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet

The endothelin pathway: a protective or detrimental target of bardoxolone methyl on cardiac function in patients with advanced chronic kidney disease?

CO-AUTHORED PUBLICATIONS